Allan J S, Coligan J E, Lee T H, Barin F, Kanki P J, M'Boup S, McLane M F, Groopman J E, Essex M
Blood. 1987 Jan;69(1):331-3.
The present studies were initiated to define the coding region of a 34 kilodalton (kd) protein (p34) frequently observed with antibodies from HTLV-III/LAV-infected people by immunoblotting and radioimmunoprecipitation (RIP) techniques. We have directly mapped this viral protein to the pol gene of HTLV-III/LAV by radiolabeled amino acid sequence analysis. This region at the 3' end of the pol gene is predicted to encode the endonuclease/integrase of the virus. The seroprevalence rate of antibodies to the pol gene products p64 and p53 and to the endonuclease p34 were evaluated. Of 161 HTLV-III/LAV seropositive people tested by immunoblotting procedures, greater than 98% had antibodies which reacted to p64/p53 and 92.6% reacted to p34 indicating that these viral proteins are highly immunogenic in nature. We have also analyzed the serum of nine healthy people living in West Africa who were infected with HTLV-IV, a closely related retrovirus. Nine of nine seropositive people had antibodies that cross-reacted to p34 of HTLV-III/LAV, whereas only seven of nine reacted to p64/p53. These studies and our earlier observations indicate that current diagnostic procedures for screening for HTLV-III/LAV infection may also detect HTLV-IV seropositive individuals, pointing to a need for more specific assay systems.
开展本研究是为了确定一种34千道尔顿(kd)蛋白质(p34)的编码区,该蛋白质通过免疫印迹和放射免疫沉淀(RIP)技术,常被感染人类嗜T淋巴细胞病毒III型/淋巴腺病相关病毒(HTLV-III/LAV)者的抗体所识别。我们通过放射性标记氨基酸序列分析,将这种病毒蛋白直接定位到HTLV-III/LAV的pol基因上。pol基因3'端的这个区域预计编码该病毒的内切核酸酶/整合酶。评估了针对pol基因产物p64和p53以及内切核酸酶p34的抗体血清阳性率。在通过免疫印迹程序检测的161名HTLV-III/LAV血清阳性者中,超过98%的人有与p64/p53反应的抗体,92.6%的人有与p34反应的抗体,这表明这些病毒蛋白本质上具有高度免疫原性。我们还分析了9名感染了密切相关逆转录病毒HTLV-IV的西非健康人的血清。9名血清阳性者中有9人有与HTLV-III/LAV的p34交叉反应的抗体,而9人中有7人有与p64/p53反应的抗体。这些研究以及我们早期的观察结果表明,目前用于筛查HTLV-III/LAV感染的诊断程序也可能检测出HTLV-IV血清阳性个体,这表明需要更特异的检测系统。